AACAP+CACAP Joint Annual Meeting
Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.
Home | Search | Browse by Day or Program | Author Index


New Research Poster Presentation 2.48
Dosing of Risperidone in Children and Adolescents with Autistic Disorder: A Double-Blind, Placebo-Controlled Study

Thursday, October 20, 2011
Stuart Kushner, M.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Xiaoping Ning, M.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Keith Karcher, M.S., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Seth Ness, M.D., Ph.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Michael Aman, Ph.D., The Nisonger Center, The Ohio State University, Columbus, OH
Jaskaran Singh, M.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
David Hough, M.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Gahan Pandina, Ph.D., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Justine Kent, M.D., Neuroscience, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
See more of: New Research Poster Session 2
See more of: New Research Poster